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Physiological responses ofT cells are directed to fragments of exogenous antigen
(antigen X) complexed to selfMHC molecules (reviewed in reference 1). The fre-
quency ofT cells recognizing individual self + Xepitopes is extremely low. T cells
showhigher responsiveness to allogeneic MHC molecules, with up to 317o ofT cells
responding toparticular allo-MHC differences. In mice, T cells also give verystrong
responses to another set ofalloantigens, termed Mls determinants (2). In fact the
precursor frequency of murine T cells for Mls determinants is even higher than
toallo-MHC (H-2) differences (3, 4). Although a number ofMls"alleles" have been
described (2), particularly strong primary anti-Mls responses are directed to Mlsa
determinants encoded on chromosome 1. Somewhat lower responses are elicited by
M1s` determinants, which have recently been shown to be encoded by a locus un-
linked to the Mls° locus (5).
As for responses to self + X and allo-H-2 epitopes, TCRaß play an important
role in controlling T cell responses to Mlsa determinants. The most direct evidence
that anti-MISa responses are TCR dependent has come from the recent finding that
T cell responsiveness to Mlsa determinants correlates with expression ofparticular
TCR Vp chains (6, 7). This finding has given rise to the idea that, like typical an-
tigen Xepitopes, Mlsa determinants are peptides that physically associate with H-
2 molecules (6). Although this notion provides a satisfactory explanation forthe TCR
dependence of anti-Mlsa responses, it should be remembered that Mlsa deter-
minants have a number of unusual properties. First, the precursor frequency ofT
cells for Mlsa determinants is far higher than to any known peptide (3, 4). Second,
whereas most peptides elicit antibody production, Mlsa determinants have yet to
be detected serologically. Third, in contrast to othercell-associated alloantigens, e.g.,
minor Hantigens, Mlsa determinants fail to act as transplantation antigens or elicit
graft-vs.-host reactions (8-10). Fourth, unlike responses to self + Xepitopes, Tcells
generally recognize Mlsa determinants across H-2 barriers (11, 12). Fifth, in con-
trast to H-2 determinants, Mlsa determinants expressed on small resting B cells are
strongly stimulatory for unprimed T cells (13). Finally, the response to Mlsa deter-
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minants is unidirectional; whereas Mlsb T cells respond strongly to MlSa stimu-
lators, the response of MlSa T cells to Mlsb stimulators is weak or absent.
In light of these unusual properties, we (14) and others (15) have suggested that
MW determinants are accessory molecules expressed on APC. According to this
idea, T cells express a complementary Mls'-reactive accessory molecule distinct
from the TCR, the function of this molecule being to augment TCR contact with
self H-2 (Ia) molecules on APC; T cell triggering occurs when the intrinsic affinity
of the TCR for Ia molecules is above a certain threshold. Although this scenario
is still highly speculative, it is of interest that a triple-reactive hybridoma responsive
to self + X, allo H-2, and MlSa determinants can lose reactivity to self + X and
allo H-2 determinants but retain Mlsa reactivity, and vice versa (14). This finding
implies that the recognition phase of Mlsa reactivity is not controlled solely by the
TCR.
If MlSa determinants fall under the category of "conventional" MHC-associated
peptides, one would expect presentation of Mlsa determinants to T cells to be a
property of any la' APC. The evidence on this point is conflicting. There are
reports that B cells (13, 16-18), macrophages (MD)' (19-21), and dendritic cells (DC)
(22) are all capable of inducing anti-Mlsa responses. However, one group observed
that spleen cells from mice given anti-p antiserum from birth to remove B cells were
unable to stimulate anti-Mlsa responses (17). Since APC function for allo-H-2 re-
sponses was maintained, the results of this study are not in accord with the view
that Ig- cells such as MO and DC can present Mlsa determinants. Therefore, the
question arises as to whether the reports that MO and DC do stimulate anti-Mlsa
responses could be attributed to minor contamination with B cells.
In this report we have used unprimed T cells and an M1sa-specific T hybridoma
to attempt to resolve the question of which cell types are capable of eliciting anti-
Mls' responses. The results confirm that spleen cells from tt-suppressed mice (gsm)
are unable to stimulate anti-Mlsa responses. In addition, evidence is presented that,
unlike B cells, preparations of M(b and DC thoroughly depleted of B cells are very
poor stimulators of Mlsa-reactive T cells. These findings suggest that very few cell
types, perhaps only B cells, have the capacity to express MlSa determinants in a
stimulatory form. Since studies with B cells differentiating in bone marrow chimeras
provided no evidence that MlSa determinants can move from one cell to another,
the data are difficult to reconcile with the view that MlSa determinants are typical
H-2-associated peptides .
Materials and Methods
Mice.
￿
B10.D2, BIO.BR, C57BL/6 (B6), (B6 x CBA/J)F,, AKR/J, DBA/2, and CBA/J
mice were obtained from The Jackson Laboratory, Bar Harbor, ME . (B6 x CBA/Ca)F,,
B10.P, D1 .LP, and some DBA/2 were obtained from the breeding colony of the Research In-
stitute of Scripps Clinic, La Jolla, CA.
Anti-u Suppression.
￿
Newborn mice were given daily intraperitoneal injections of affinity-
purified rabbit anti-mouse u antibodies (23) from day 0 to 5 (0 .2 mg in 100 gl/injection).
' Abbreviations used in thispaper: CAS, supernatant from Con A-stimulated spleen cells; DC, dendritic
cells; FyG, fowl gamma globulin; LN, lymph node; Mq), macrophages; wsm, g-suppressed mice; PEC,
peritoneal exudate cells; RPC, resident peritoneal cells.WEBB ET AL.
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Thereafter, the injections were given three times per week (0.4 mg in 200 Al/injection). In
each experiment, wsm were checked for percentage of Ig' B cells by staining with FITC
anti-Ig.
Chimeras.
￿
Mice were irradiated with a'3'Cs source delivered by a y cell 40 irradiator (90
rad/min). Within 12 h of irradiation the mice were reconstituted with bone marrow cells
pretreated with antiThy-1 mAb and C'. The mice were left for 5-8 wk before the experiment.
ProductionandAssay of T Hybridoma.
￿
The triple-reactive T clone used for fusion has been
previously described (24). This B10.D2 clone reacts (a) to fowl gamma globulin (FyG) plus
H-2d, (b) to allo H-2P,6.9 , and (c) to Mlsa determinants; the clone recognizes Mlsa deter-
minants in the context ofall H-2 haplotypes tested including k, d, v, and u. Using standard
techniques (14), the clone was fused to the TCR-a- /ß- mutant of BW5147 derived by the
Marrack/Kappler group. The resulting triple-reactive T hybridoma, KW.3, was maintained
in DMEM (Gibco Laboratories, Grand Island, NY) containing 10 17o NCTC 109, 10% FCS,
glutamine, 2-ME, and antibiotics. The specificity of the hybrid was assayed by stimulation
of IL-2 production (14): 1-2 x 105 T hybrids were cultured with the indicated stimulator
cells; 24 h later serial dilutions of the culture supernatants were added to 5 x 103 IL-2-
dependent HT2 cells for an additional 24 h. The cultures were then pulsed with [3H]thymi-
dine for 16-18 h before harvest on glass fiber filters.
MLR.
￿
The culture media used for MLR was RPMI 1640 (Gibco Laboratories) containing
10% FCS, 5% NCTC 109, glutamine, 5 x 10-5 M 2-ME, and antibiotics. Indomethacin,
a prostaglandin inhibitor, was included in the culture media at a concentration of 10-6 M
as a precaution against nonspecific negative effects of macrophages. It was found to have
a significant enhancing effect on the specific response in some experiments. 1-2 x 105 lymph
node (LN) T cells were cultured with various concentrations of the indicated stimulators in
flat-bottomed microtiter wells for 4 d; responses obtained at optimal concentrations of the
indicated stimulators are shown. The cultures were pulsed with [3H]thymidine during the
last 18 h of culture. In most experiments CD4' T cells were enriched by incubating LN cells
at 37°C for 1 h with C' plus a mixture of mAb reactive to B cells (J11d) and CD8' cells
(3.168)(25). In some experiments, including the ones illustrated in Tables II and III, T cells
were purified by passage over nylon wool columns before treatment with antibody + C'.
Preparation ofDC.
￿
DC were prepared according to Steinman et al. (26). Briefly, spleen
cells were allowed to adhere to plastic tissue culture dishes. After 2-3 h the plates were gently
washed free of nonadherent cells and the adherent cells were incubated overnight. Nonad-
herent (floating) cells were then removed from the dishes and allowed to readhere for 1-2 h.
The nonadherent cells (DC-enriched cells) were harvested. In some experiments these cells
were further purified by treatment with J11d mAb + C' at 37°C for 1 h followed by washing;
J11d mAb + C destroy nearly all Ig' B cells, neutrophils, and erythrocytes but spares T
cells and the majority of Mo and DC (27 and J. Sprent and M. Schaefer, unpublished data).
Preparation ofPeritoneal Cells.
￿
Resident peritoneal cells were obtained from mice injected
intraperitoneally 24 h before harvest with 1 ml of supernatant from Con A-stimulated spleen
cells (CAS). For peritoneal exudate cells (PEC), mice were injected with 2 .5 ml i.p. of a 3%
sterile solution of thioglycollate medium. 2-3 d later these mice received 1 ml i.p. of CAS;
PEC were collected 24 h later. Peritoneal cells were further purified by treating with Jlld
mAb + C' at 37° before culture.
Purification ofB Cells.
￿
B cells were purified from pooled LN and spleens (13). After lysis
oferythrocytes, the cells were incubated for 2 h on plastic (tissue culture 3003 ; Falcon Lab-
ware, Oxnard, CA) followed by two sequential passages through G10 columns. The resulting
adherent cell-depleted suspension was further purified by incubation with a mixture of anti-
Thy-1 (J1j) (27), anti-Mac 1 (M1/70) (13), and anti-DC (33Dl) (28) mAb + C'. Such B cells
are >99% IgM' and contain undetectable numbers of latex ingesting cells. For Exp. 2 of
TableV these B cells were further fractionated on Percoll density gradients as described (13)
and only the less dense fraction was used. This fraction was previously shown to stimulate
self + X and allo-H-2 responses as well as anti-Mlsa responses (13 and Webb, unpublished
observation). Before use as stimulators, B cells were incubated with 25 ug/ml mitomycin C
at 37°C for 30 min, followed by three washes.4
￿
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Results
Experimental Design.
￿
For measuring primary MLR, purified LN T cells or CD4+
cells from mice ofthe nonstimulatory Mlsb allele were cultured with irradiated H-
2-different stimulators vs. H-2-compatible Mlsa-positive stimulators; it should be
noted that some Mlsa-positive strains, e.g., CBA/J, also express Mls` determinants.
In some experiments Mlsa determinants were detected with the aid of an Mlsa-
reactive T hybridoma; this hybridoma also reacts to certain alto-H-2 determinants
(H-21''b,q) and to self MHC/X epitopes (H-2d plus FyG).
APC Function of Spleen Cellsfrom B Cell-depleted u-suppressed Mice.
￿
At the outset
ofthese experiments, we considered it of utmost importance to reassess the claim
ofAhmed et al. (17) that lymphoid cells from wsm are unable to stimulate anti-Mlsa
responses. To deplete mice ofIgM+ B cells, CBA/J (H-2k, Mlsa) mice were given
repeated injections of purified rabbit anti-mouse g chain antibodies from birth
(Materials and Methods). In accordance with previous findings (23), the spleens
ofthese mice tested at 6 wk of age were essentially devoid of IgM F B cells. When
used as a source of APC for primary MLR, Thy-1 - spleen cells from CBA/J usm
failed to stimulate an anti-M1sa response by H-2-compatible B10.BR (H-2k, Mlsb)
T cells (Table I). Normal Thy-1 - CBA/J spleen cells, by contrast, were strongly
stimulatory for B10.BR T cells. Although CBA/J wsm spleen cells failed to present
M1sa determinants, these spleen cells retained the capacity to stimulate anti-H-2
responses. Thus, when used as stimulators for H-2-incompatible B10.D2 (H-2k,
Mlsb) T cells, CBA/J usm spleen cells elicited approximately the same response as
B10.BR spleen cells.
The failure of4sm spleen cells to stimulate anti-Mlsa responses applied not only
to CBA/J usm (Table I) but also to DBA/2 (H-2d, M1sa) and DLLP (H-2b, Mlsa)
psm (data not shown). With all three strains, doses of Thy-1 - 4sm spleen cells
ranging from 5 x 104 to 5 x 105 elicited virtually no anti-Mlsa response, but stimu-
lated strong anti-H-2 responses. Suppression did not appear to be involved because
TABLE I
Primary MLR to Mlsa vs. Alto-H-2 Determinants: Failure of Spleen Cells
from B Cell-depleted usm to Stimulate Anti-Mlsa Responses
usm were treated from birth with affinity-purified rabbit anti-11 antibody
(Materials and Methods).
* 2 x 105 T cell-enriched responders (lymph node cells treated with Jlld mab
+ C') were cultured with 5 x 105 irradiated (1,500 rad) anti-Thy-1 +
C'-treated spleen cells for 4 d. During the last 18 h each culture was pulsed
with 1 uCi [3H]TdR.
II Mean of triplicate cultures.
Thy-1 - stimulators (H-2,Mls)
[3H]TdR Uptake responders*
B10.BR 1310.132
(H-2k,Mlsb) (H-2d,Mlsb)
cpm x 10-3
Normal B10.BR (k,b) 1.311 48 .4
Normal B10.D2 (d,b) 34 .3 2 .1
Normal CBA/J (k,a/c) 162 .5 276 .4
usm CBA/J (k,a/c) No. 1 2.4 58 .3
(k,a/c) No. 2 2 .9 49 .5WEBB ET AL.
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adding psm spleen to normal Mlsa-positive spleen cells failed to cause inhibition.
The data thus confirm the findingofAhmed et al. (17) that g.sm spleen cellscontain
APC for anti-H-2 responses but lack APC for anti-Mlsa responses.
APC Function ofDC
￿
The above data are difficult to reconcile with reports that
normal Md) and DC elicit anti-Mlsa responses (see Introduction). One explanation
for this discrepancy is that Mth and DC in psm do not make contact with B cells
and so are unable to absorb Mlsa determinants from these cells. To examine this
question, DC were prepared from spleens ofnormal mice and tested for their ca-
pacity to stimulate anti-Mlsa vs. anti-H-2 responses. To ensure that the anti-H-2
responses were directed to class II (Ia) determinants rather than to class I deter-
minants, CD4+-enriched T cells were used as responder cells (Materials and
Methods).
In initial experiments, preparations ofnormal DC elicited veryhigh anti-H-2 re-
sponses but also stimulated high anti-Mlsa responses. Since our DC preparations
were found to contain Ig+ cells, DC suspensions were depleted ofB cells by treat-
ment withJ11d mAb + C. As shown in Table II, Jlld- DC were strongly stimula-
tory for anti-H-2 responses. Thus, B10.BR CD4' T cells responded as effectively
toJlld + C-treated B10.P (H-2r) DC as to untreated 1310Y DC. For anti-M1sa re-
sponses, however, J11d - DC failed to stimulate. Thus, B10.BR CD4' cells
responded wellto untreated AKR/J DC but gaveonly background responses toJ11d
+ C-treated AKR/J DC. A more comprehensive experiment withJ11d- DC from
four different strains is shown in Table III. It can be seen that, in contrast to Thy-
1 - spleen cells, Jlld - DC from AKR/J and CBA/J mice failed to stimulate H-2-
compatible Mlsa-reactive 1310.BR CD4+ cells. These same DC, however, were
strongly stimulatory for H-2-different 1310.132 CD4' cells.
The inability ofB-depleted DC to stimulate anti-Mlsa responses applied not only
to unprimed CD4+ responders but also to T hybridoma cells. Thus, as shown in
Table III, the Mlsa-reactive Thybridoma responded well to Mlsa-positive CBA/J
TABLE II
Primary MLR Elicited by DC. Jlld - DC Stimulate Anti-H-2 MLR
but not Anti-MlSa MLR
Primary MLR were measured by culture of 2 x 105 CD4' T cells (Nylon
wool-purified lymph node cell suspensions treated withJlld + anti-Lyt-2 mab
+ C') with either 5 x 105 Thy-1- splenic APC or 2.5 x 104 purified DC pre-
pared from spleen (Materials and Methods); both stimulator populations were
irradiated (1,500 rad). Cultures were incubated for 4 d and pulsed with
[3H]TdR during the last 18 h.
* Mean of triplicate cultures.
Stimulator
strain (H-2, MIS) Stimulus
Treatment
of DC
Proliferative response
([3H]TdR uptake)
of B10 .BR CD4' T cells
CpM x 10 -3
B10.BR H-2k, Mlsb Self - 10.5*
Jlld + C' 10.9
B10 .P H-2P, Mlsb H-2P - 71 .5
Jlld + C' 73.5
AKR/J H-2k, Mlsa MIS' - 131 .5
Jlld + C' 8.16
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TABLE III
Anti-Mls° Responses by Normal CD4+ T Cells vs. T Hybridoma Cells:
Responsiveness to 7by-1 - Spleen Stimulators but not to jlld - DC
" IL-2 production of T hybridoma in response to stimulators measured at 24 h; supernatants from primary
cultures were incubated with the 11-2-sensitive indicator line HT-2 . The hybridoma reacts to Mls' deter-
tninants and also expresses alloreactivity for H-21"'í .
MLR were measured as for Table 11; T cells were purified as in Table 11 . Spleen stimulators were treated
with anti-Thy-1 mAb + C' and DC were treated with jlld + C'; the stimulators were irradiated (1,500
rad) before use.
9 Mean of triplicate cultures.
and AKR/J spleen cells but was totally unresponsive to DC from these strains. As
a manifestation of H-2 alloreactivity, the T hybridoma responded well to DC ex-
pressing H-21' (B6) determinants (Table 111).
The above data refer to DC preparations depleted of B cells by J11d mAb + C
treatment . In one experiment, mAb 14.8, specific for B220 molecules, which are
expressed on all B cells (29), was used to fractionate AKR/J DC by FACS. The T
hybridoma gave no detectable response to the B220 - fraction of AKR/J DC, al-
though these B220- cells were strongly stimulatory for H-2-reactive DBA/2 T cells
in primary MLR (data not shown).
APC Function ofM(D.
￿
Cell populations enriched for M(D were obtained from the
peritoneal cavity of normal mice or mice given thioglycollate 3 d before. To enhance
la expression, the MO donors were given CAS intraperitonally 1 d before harvest.
Before use as stimulators, peritoneal cell preparations were pretreatedwithJ11d mAb
+ C to remove Ig+ cells. In preliminary experiments, resident peritoneal cells
(RPC) and PEC were tested for their capacity to stimulate primary anti-H-2 MLR,
using normal CD4+ cells as responders. With both M(b populations, primary MLR
were negligible, even in the presence of indomethacin and over a wide dose range
of stimulators (data not shown). With T hybridoma cells, however, MO were clearly
able to present allo-H-2 (H-2b) determinants (Table IV). Thus, in addition to
reacting to B6 spleen and DC, the T hybridoma responded well to B6 RPC and
PEC. Significantly, this hybridoma gave no detectable response to AKR/J RPC or
PEC, i .e., cells of Mlsa genotype (Table IV); strong responses were observed with
AKR/J spleen cells. Thus, like DC, peritoneal M(D presented H-2 (la) alloantigens
but failed to present Mlsa determinants.
APC Function of Purified B Cells.
￿
As discussed earlier (see Introduction), resting
T cells give strong anti-Mlsa responses to purified B cells (13) . This is illustrated
in Table V. The responses of T hybridoma cells to highly purified B cells as APC
[iH]TdR Uptake with stimulators
Responders
BIO .BR
(H-2k,Mls")
Spleen DC
CBA/J
(H-2k,Mls`'/`)
Spleen DC
AKR/J
(H-2k,Mls°)
Spleen DC
(H-2h,Mlst')
Spleen
B6
DC
B10 .D2
(H-2`t,MIP)
Spleen DC
cpm x 10 - j
T Hybridoma" 0.0 0 .6 48.8 0.2 39.3 0 .4 33.9 28.0 ND ND
B10.BK1
CD4' Cells 4.1 6.8 287 .9 7 .1 60.4 2 .4 34.6 72.5 ND ND
BIO .D2
CD4` cells 152.5 127.9 154.2 126.9 183.6 52.0 87 .0 76.5 12.6 NDWEBB ET AL.
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TABLE IV
APC Function of CAS-induced Mo Populations for T Hybridoma.
Mo Present Allo-H-2 (H-2b) Determinants but not Misa Determinants
" Spleen cells were treated with anti-Thy-1 mab + C'. Thioglycollate-induced PEC were from
mice that received 2.5 ml i.p. of 3% thioglycollate at day - 3 and 1 ml i.p. of CAS on day
- 1 (Materials and Methods). RPC were from mice that had received 1 ml i.p. CAS at day
- 1 . All Mo and DC preparations were treated with Jlld + C' to remove B cells and were
then irradiated (1,500 rad) .
IL-2 production by T hybridoma; see Table 111.
4 Mean of triplicate cultures.
is also shown; B cells were prepared from spleen and LN by removal of adherent
cells on plastic followed by passage on G10 and treatment with antiThy-1, 33D1,
and C'. It can be seen that B cells were highly effective APC for each of the three
ligands recognized by the hybridoma, i.e., FyG + self H-2d (B10.D2), allo-H-
2P(B10.P), and Mlsa (CBA/J).
Can B CellsAbsorb M1sa Determinantsfrom other B Cells In Vivo?
￿
One explanation
for the failure of DC and M-0 to express Mlsa determinants is that these deter-
minants are incapable ofmoving in intact form from one cell to another. To address
this question, we examined whether Mlsa-negative B cells, i.e., B6 B cells, could
absorb Mlsa determinants in a chimeric enviroment. The experimental system used
here was to transfer a mixture of Tdepleted B6 (H-2b, Mlsb) and CBA/J (H-2k,
Mlsa) bone marrow cells into heavily-irradiated (1,100 rad) (B6 x CBA/Ca [H-2b,
Mlsb x H-2k, Mlsb])F1 mice (see Table VI,footnote). The recipients were left for
5-8 wk to allowthe formation of a mixedpopulation of 136 and CBA/J Bcells. Would
the B6 B cells absorb Mlsa determinants from the CBA/J B cells? This question
was addressed by fractionating the spleen cells into 136 (H-2b) and CBA/J (H-2k)
B cell-enriched populations with the aid ofappropriate anti-H-2 alloantibody mAb
plus C' (in addition to antiThy-1 mAb).
Strain
Stimulators
Cell type'
No. of stimulators
for T hybridomas
[3H]TdR Uptake
by HT-2 cells:
cpm x 10-3
B10 .BR Spleen (Thy 1 - ) 5 x 105 0.14
(H-2k,Mlsb) TG-PEC (Jlld- ) 5 x 104 0.1
(RPC (Jlld- ) 2 x 104 0.1
DC (Jlld - ) 2 x 104 0.1
AKR/J Spleen (Thy 1 - ) 5 x 105 40.7
(H-2k,Mlsa) TG-PEC (Jlld- ) 5 x 104 0.1
104 0.1
RPC (Jlld- ) 2 x 104 0.3
104 0.1
DC (Jlld - ) 2 x 104 0.2
B6 Spleen (Thy 1 - ) 5 x 105 31 .7
(H-2b,Mlsb) TG-PEC (Jlld- ) 5 x 104 14.8
2 .5 x 104 4.2
104 0.4
RPC (Jlld- ) 2 x 104 38.7
104 11 .8
DC (Jlld- ) 2 x 104 35.48
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TABLE V
APC Function of Purled B Cells for T Hybridoma Cells
' B10 .BR CD4' responder cells (2 x 105/culture) were prepared by passing LN cells through nylon wool
columns and then treating the recovered cells with anti-CD8 mAb + C.
$ Spleen stimulators were pretreated with anti-Thy-1 mAb + C. Purified B stimulators were prepared from
pooled spleen + LN as described in Materials and Methods. For Exp. 2 (but not Exp . 1), the purified
B cells were separated on Percoll gradients to obtain a fraction of low-density B cells ; in our hands (13
and Webb, unpublished results), these latter cells are more effective than typical high-density B cells in
presenting self + X (FyG) epitopes. All stimulator cells were used at a dose of 5 x 105/culure and pretreated
with mitomycin C (not irradiation).
§ For the MLR by CD4' cells, responses were measured on day 4 as for Table 11. For the response of the
T hybridoma, IL-2 production was measured as for Table III.
TABLE VI
Anti-Mls' MLR Elicited by Thy-1 - Spleen Cells from B6 + CBA/J - 1,100-rad
(B6 x CBA/Ca)FI Chimeras: no Stimulation with Anti-l-Ak + C-treated Spleen Cells
[3H]TdR Uptake responders
Exp.
2
(B6 x CBA/Ca)Fl mice were irradiated (1,100 rad) and reconstituted intravenously with a mixture ofT-de-
pleted B6 marrow (107/mouse) and CBA/J marrow (5 x 106/mouse). Higher numbers of B6 marrow cells
were given to overcome Hh resistance. At 5 wk (Exp. 1) or 8 wk (Exp. 2) after reconstitution, the chimeras
were tested for Mlsa-specific APC function. Doses of 2 x 105 CD4+ responder cells (Table III) were cul-
tured for 4 d with 5 x 105 irradiated (1,500 rad) Thy-1 - spleen cells for 4 d and pulsed with [3H]TdR dur-
ing the last 18 h of culture. Where indicated, the chimera spleen stimulators were pretreated with either
anti-I-Ak (11 .5.2) + anti-Thy-1 mab + C' or with anti-I-Ab (28.16 .ßs) + anti-Thy-1 mab + C' (30) . All
stimulators were washed four times before culture.
Exp. Responders* APC1
BIO.D2
(H-2d,Mlsb)
[3H]TdR
B10.D2/FyG
Uptake with stimulators
B10.BR CBA/J
(H-2k,Mlsb) (H-2k,Mlsa/`')
1310.1'
(H-2P,Mlsb)
Cp. x 10-,s§
1 B10.BR CD4' Spleen - - 2.6 276.2 111 .2
B cells - - 0.4 280 .2 32.3
T hybridoma Spleen - - 0.4 49 .8 49.2
B cells - - 0.5 47 .6 48.4
2 T hybridoma Spleen 0.2 18.5 - 56.9 40.6
B cells 0.4 18 .8 - 58 .4 47.6
Strain
Stimulators
H-2,Mls Treatment
B6
(H-2b,Mlsb)
(B6 x CBA/Ca)Fj
(H-2b,Mlsb x
H-2k,Mlsb)
cpm x 10 - '
B10 .BR
(H-2k,Mlsb)
136 b,b - 6.3 3.4 30.7
(B6 x CBA/Ca)Fl bxk,bxb - 31 .8 3.5 29.0
DLLP b,a - 50.9 73.1 127 .8
(B6 x CBA/J)Fl bxk,bxa/c - 97 .2 100.4 98.0
Chimera 1 - 54.8 65.4 68.9
Anti-I-Ab + C 47.9 89.0 23 .4
Anti-I-Ak + C' 2 .2 2.0 20.0
Chimera 2 - 48 .3 52.9 34.8
Anti-I-Ak + C' 1 .8 0.9 15.3
Chimera 3 - 118.8 81 .6 126.5
Anti-I-Ak + C' 1 .5 0.7 21 .9
Chimera 4 - 61 .2 26.6 47.3
Anti-I-Ak + C 2 .9 1 .7 44.7WEBB ET AL.
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The results ofthis experiment are shown in Table VI. Unseparated spleen cells
from the chimeras, as well as anti-I-Ab + C-treated spleen cells, were strongly
stimulatory for (B6 x CBA/Ca)Fl T cells, i.e., for Mlsa-reactive cells. Significantly,
however, removing CBA/J cells from the spleen suspensions with anti-I-A' mAb +
C (which destroyed only N507o ofthe spleen cells) completely removed the capacity
to stimulate anti-Mlsa responses. Thus, the B6 cells surviving anti-I-A' + C treat-
ment were totally nonstimulatory for Mlsa-reactive syngeneic B6 and semisyngeneic
(B6 x CBA/Ca)Fi T cells but retained the capacity to stimulate H-2-different
B10.BR T cells. These findings thus provided evidence that B6 cells cannot absorb
(and/or process) M1sadeterminants from CBA/J cells during prolonged cell-to-cell
contact in vivo.
Discussion
Although various Ia+ cell populations can present antigen to sensitized T cells,
APC function for unprimed T cells seems to be largely restricted to DC (31). The
decisive influence ofDC on the function ofunprimed T cells applies to typical self
H-2/X responses as well as to anti-H-2 MLR. Responses to Mlsa determinants,
however, seem to be exceptional in two respects. First, as mentioned earlier (see In-
troduction), strong primary MLR to MISa determinants can be elicited by highly
purified populations ofnormal B cells (13). Second, the datapresented in this paper
suggest that B cell-depleted populations, including purified DC, fail to elicit anti-
Mlsa responses.
The finding that B-depleted psm spleen cells, as well asJ11d- DC and MO from
normal mice, were all unable to stimulate anti-Mlsa responses raises the possibility
that Mlsa determinants are expressed solely on B cells. Although the data are in
accord with this notion, the possibility that MISa determinants are expressed on a
minor subset of Ig- cells cannot be ruled out. It is also conceivable that some cells
express Mlsa determinants in nonstimulatory form. Thus, given that anti-Mlsa re-
sponses appear to require corecognition ofIa molecules (3, 6, 7), expression ofMlsa
determinants on Ia- cells would presumably go undetected. In this respect it should
be mentioned that T cells from psm show at least partial tolerance to "self" Mlsa
determinants (Webb, unpublished results). Whether this finding reflects theexpres-
sion of Mlsa determinants on non-B cells or has some other explanation (e.g.,
homing of small numbers of Ig+ cells to the thymus prenatally) is still unclear.
The failure to find convincing evidence ofMISa expression by non-B APC makes
it difficult to argue that MISa determinants represent typical MHC-associated pep-
tides. It is also noteworthy that Mlsa-negative B cells did not absorb detectable levels
of Mlsa determinants in appropriate bone marrow chimeras (Table VI). This
finding contrasts with reports that certain other H-2-associated alloantigens, e.g.,
minor H antigens (32) and ß2-microglobulin (33), do move freely from one cell to
another. The data also contrast with the observation ofMarrack and Kappler (34)
that an allo I-E-associated epitope recognized by Vp17a+ T cells is expressed on B
cells and fresh MO (RPC) but is not found on cultured M(D; the authors suggested
that the I-E-associated epitope is B cell derived but can be absorbed by MO and
displayed in processed form. Since we failed to detect MISa determinants on fresh
MO, it would appear that MISa determinants are fundamentally different from the
I-E-associated epitope studied by Marrack and Kappler (34).10
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Two other models for MlSa recognition require consideration. First, M1sa deter-
minants on B cellsmight be expressedon a cell surfacemolecule that associates with
H-2 (Ia) molecules, butwithoutprocessing (breakdowninto peptides)(datanot shown).
T cells could then recognize this complex via a single TCR combining site. This
model is compatible with much ofthe available data (e.g., references 6 and 7), but
it fails to explain our finding that anti-Mlsa reactivity segregates independently
from self + X and allo H-2 reactivity in T hybridomas (14). For this reason we
favor a model in which the recognition phase of anti-Mlsa responses involves an
extra T cell molecule (which we envisage as an accessory molecule). For this model
it is not necessary to postulate that Mlsa determinants enter into a physical associ-
ation with la molecules.
Until MlSa determinants are characterized biochemically, no model for Mlsa rec-
ognition by T cells can be put forward with any degree of confidence. The data in
this paper do not clarify the physiological status of MlSa determinants. However,
the data do suggest strongly that Mlsa determinants are highly unusual and do not
fit easily into the category of typical self + X epitopes.
Summary
Evidence was sought on the tissue distribution of MlSa determinants, a class of
cell-associated non-H-2 alloantigens that is highly immunogenic for unprimed T
cells. Whereas normal CD4+ Tcells and an Mlsa-reactive T hybridoma gave strong
responses to Mlsa-positive stimulator populations containing Ig+ B cells, anti-Mlsa
responses to B-depleted stimulatorswere almost undetectable. The B-depleted stimu-
lators tested included Thy-1 - spleen cells from 4-suppressed mice (mice treated with
anti-p antibody from birth) andJ11d- preparations of spleen dendritic cells (DC)
and peritoneal macrophages (MO) from normal mice. Each of these populations
was strongly immunogenic for allo-H-2-reactive T cells.
The failure to detect Mlsa determinants on Ig- APC, i.e., M(D and DC, suggests
that MlSa determinants are not typical H-2-associated peptides. The data are more
compatible with a model in which MlSa determinants represent (or form part of)
an integral cell membrane molecule expressed largely, and perhaps exclusively, on
B cells. T cells might recognize these molecules only in native form, "processed"
MlSa determinants being nonimmunogenic. Consistent with this possibility, no evi-
dence was found that Mlsa-negative B cells could absorb Mlsa determinants from
Mlsa-positive B cells in a chimeric environment.
Receivedfor publication 11 july 1988 and in revisedform 14 September 1988.
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